Company: BACC
Filing Date: 2025-05-14
Form Type: S-1
Source: 0001185185-25-000465
Chunk: 353

Company: Blue Acquisition Corp/Cayman
Filing Date: 2025-05-14
Form: S-1
Chunk 353
---
 size of this offering would be a maximum of 17,250,000 units if the underwriters’ over-allotment option is exercised in full and therefore that such founder shares would represent 26% of the outstanding shares after this offering (excluding the private placement shares). Up to 790,425 of these shares will be surrendered for no consideration depending on the extent to which the underwriters’ over-allotment is exercised.

Our sponsor is an accredited investor (as defined in Rule 501 of Regulation D). Each of the equity holders in our sponsor is an accredited investor under Rule 501 of Regulation D. The sole business of our sponsor is to act as the company’s sponsor in connection with this offering.

<div align='center'>II-1</div>

Our sponsor and BTIG and Roberts & Ryan, the underwriters,
have committed, pursuant to written agreements, to purchase from us an aggregate of 490,000 private placement units (or 535,000 private
placement units if the underwriters’ over-allotment option is exercised in full) at $10.00 per unit for an aggregate purchase price
of $4,900,000 (or $5,350,000 if the underwriters’ over-allotment option is exercised in full) in a private placement that will close
simultaneously with the closing of this offering. Of those 490,000 private placement units, our sponsor has agreed to purchase 340,000 private
placement units (or 362,500 units if the underwriters’ over-allotment option is exercised in full) and BTIG and Roberts & Ryan
have agreed to purchase 150,000 private placement units (or 172,500 private placement units if the underwriters’ over-allotment
option is exercised in full). These purchases will take place on a private placement basis simultaneously with the completion of our initial
public offering. This issuance will be made pursuant to the exemption from registration contained in Section 4(a)(2) of the
Securities Act.

No underwriting discounts or commissions were paid with respect to such sales.

Item 16. Exhibits and Financial Statement Schedules.

Exhibit Index

| Exhibit No. |     | Description                                                                                                                        |
| 1.1*        |     | Form of Underwriting Agreement.                                                                                                    |
| 3.1         |     | Memorandum and Articles of Association of the Registrant.                                                                          |
| 3.2*        |     | Form of Amended and